Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Jun 14, 2021 9:08pm
123 Views
Post# 33386296

RE:RE:RE:RE:RE:We lost 1/2 our share price since launch..

RE:RE:RE:RE:RE:We lost 1/2 our share price since launch..

0.2% x 15 ml = 0.03 mg.      0.03 mg x $8000 US per kg => $0.00024 US per tube?



MirrorWorldMan wrote: So many details were not released, many investors prior to launch were projecting 100ml tubes of skin lightener, thereby using 2g per tube. Instead we only see a 15 ml tube of targeted application on dark spots only, thats only .3 mg per tube! a little more that 15% of what was assumed to be the contents, hence 15% of the revenue projections. Sirona only gets $2.40/tube royalty on a $66 tube of Targeted Dark Spot Corrector, and 1067 is the active ingredient or 3.6% royalty.   Where is the skin Lightener cream  thats supposed to replace the toxic Hydroquinone for general purpose lightening in the asian population?

 

<< Previous
Bullboard Posts
Next >>